CAMP4 Therapeutics Corporation Common Stock, Capital Shares Reserved for Future Issuance
CAMP4 Therapeutics Corporation (CAMP) had Common Stock, Capital Shares Reserved for Future Issuance of 43.92 million shares as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-05
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 43.92M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 43.81M shares.
- 2025-06-30: Common Stock, Capital Shares Reserved for Future Issuance 5.18M shares.
- 2025-03-31: Common Stock, Capital Shares Reserved for Future Issuance 5.22M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 43.92M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 43.81M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 5.18M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 5.22M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 4.43M shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 14.63M shares 10-Q · filed 2024-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |